[Form 4] Lemonade, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Timothy E. Bixby, Chief Financial Officer of Lemonade, Inc. (LMND), was granted a stock option on 08/21/2025 for 127,780 shares with an exercise price of $59.74 per share. The option vests in 12 equal quarterly installments beginning on 08/18/2025 and expires on 08/18/2035. The report indicates the shares underlying the option total 127,780 common shares and are listed as directly beneficially owned following the transaction. Vesting is conditioned on the reporting person’s continued employment through each vesting date. The Form 4 is signed by Mr. Bixby on 08/25/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: A sizable CFO option grant was reported, standard for executive compensation but potentially dilutive depending on company share count.
The Form 4 discloses an option award of 127,780 shares at a $59.74 exercise price, vesting quarterly over three years starting 08/18/2025 and expiring 08/18/2035. From a capital-markets perspective this appears to be a compensation award intended to align the CFO with long-term shareholder value. The filing does not disclose total outstanding shares or the grant’s accounting treatment, so the direct dilution impact and expense recognition cannot be assessed from this document alone. No other transactions or dispositions were reported.
TL;DR: Grant structure is typical: multi-year vesting and a 10-year option term to incent retention and performance.
The award vests in 12 equal quarterly installments beginning shortly before the first vesting date, which implies roughly three years of service-based vesting. A $59.74 strike and ten-year contractual term are conventional for option grants. The filing confirms vesting is conditioned on continued employment but does not attach performance conditions or forfeiture provisions beyond that. Absent company-wide grant policy details, this appears to be a routine but material executive equity award.